APA (7th ed.) Citation

Brandhorst, G., Weigand, S., Eberle, C., Raddatz, D., Karaus, M., Oellerich, M., & Walson, P. (2013). CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity. Clinica chimica acta, 421, 31-33. https://doi.org/10.1016/j.cca.2013.02.016

Chicago Style (17th ed.) Citation

Brandhorst, G., S. Weigand, C. Eberle, D. Raddatz, M. Karaus, M. Oellerich, and P.D Walson. "CD4+ Immune Response as a Potential Biomarker of Patient Reported Inflammatory Bowel Disease (IBD) Activity." Clinica Chimica Acta 421 (2013): 31-33. https://doi.org/10.1016/j.cca.2013.02.016.

MLA (9th ed.) Citation

Brandhorst, G., et al. "CD4+ Immune Response as a Potential Biomarker of Patient Reported Inflammatory Bowel Disease (IBD) Activity." Clinica Chimica Acta, vol. 421, 2013, pp. 31-33, https://doi.org/10.1016/j.cca.2013.02.016.